What is a recommended approach to assess and manage risk in a patient with polypharmacy and multiple comorbidities?

• A. Ignore drug interactions in most cases
• B. List medications, assess interactions, consider competing risks, simplify where possible, and monitor for adverse effects
• C. Stop all medications to avoid interactions
• D. Rely solely on patient self-report without cross-checking

Answer: (B)

Managing risk in a patient with polypharmacy and multiple comorbidities requires a structured, patient-centered medication review. Start with a comprehensive list that includes all prescriptions, over-the-counter drugs, and supplements, then evaluate for drug-drug interactions, duplications, dosing issues, and cumulative risks such as anticholinergic or QT-prolonging burden. Consider competing risks—benefits of a medication for one condition may be offset by harms in another—and prioritize therapies based on the patient’s goals and overall prognosis, simplifying or de-prescribing where possible while preserving essential treatments. Ongoing monitoring for adverse effects, efficacy, and adherence is crucial, with coordination among prescribers to ensure safety and continuity of care. This approach directly targets safety by identifying interactions, reducing regimen complexity, and catching problems early, whereas ignoring interactions, stopping all medications, or relying solely on patient self-report without cross-checking can lead to preventable harm.